Clinical Trial Update: Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer

View source ↗

Summary

A clinical trial is recruiting to evaluate a Pan-CK-targeting NIR-II fluorescent probe for rapid assessment of sentinel lymph node metastasis in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pan-CK-targeting NIR-II fluorescent probe

Snippet

Sponsor: Yunnan Cancer Hospital | Conditions: Breast Cancer Metastatic, Sentinel Lymph Node | Status: RECRUITING